ReviewNanomaterials (Basel, Switzerland)2025
MXene/MOF-Derived Composites with Multidimensional Nanostructures: Synthesis Methods, Performance, and Applications in the Field of Energy Storage.
Review in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Hierarchical NiV-LDH Nanosheet Arrays Vertically Grown on MXene-Embedded Carbon Nanofibers for High-Performance Flexible Supercapacitors.Nanomaterials (Basel, Switzerland) · 2026Article
- MXene-based materials for oil-water separation: mechanisms, performance, environmental implications, and future directions.RSC advances · 2026Review
- In-Situ Growth of Carbon Nanotubes on MOF-Derived High-Entropy Alloys with Efficient Electromagnetic Wave Absorption.Materials (Basel, Switzerland) · 2026Article
- Multiscale Ion-Electron Transport in 3D-Printed Hierarchically Porous Full Batteries.Nanomaterials (Basel, Switzerland) · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Metal-organic frameworks (MOFs), formed by the self-assembly of metal ions/clusters and organic linkers, have attracted considerable attention due to their well-exposed active sites, exceptionally high porosity, and diversified pore architectures. MOF-derived materials obtained through high-temperature pyrolysis or composite structural design not only inherit the porous framework advantages of their precursors but also demonstrate significantly enhanced electrical conductivity and structural stability via the formation of carbon-based frameworks and in situ transformation of metallic species. However, conventional MOF-derived materials struggle to address persistent technical challenges in contemporary energy storage systems, particularly those requiring ultralong cycling stability and ultrahigh-rate capability under practical operating conditions. The integration of MXene, characterized by its abundant surface functional groups (-O, -OH, -F) and exceptional electrical conductivity, with MOF-derived materials presents a viable strategy to address these challenges. Multidimensional nanocomposites constructed through in situ growth and self-assembly techniques synergistically integrate MXene's conductive network scaffolding effect with the structural tunability of MOF-derived frameworks. This unique architecture enables the following: (i) enhanced exposure of electroactive sites, (ii) optimized ion diffusion kinetics, (iii) mechanical integrity maintenance, collectively boosting the applicability of MXene/MOF hybrids in advanced energy storage systems. This review summarizes the synthesis methods, energy storage performance, and applications of multidimensional nanostructured MXene/MOF-derived composites. Finally, it discusses the opportunities and challenges for MXene/MOF-derived composites in future energy storage applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.